Latest News
Latest News
TV ads must trumpet drug prices, Trump administration says. Pharma tries a Plan B.
If approved, the proposed rule has no government enforcement mechanism that would force the companies to comply.
From the Journals
Higher rate of loss seen in unplanned pregnancies for women with epilepsy
Pregnancy planning, maternal age, and interpregnancy interval proved to be significant modifiable risk factors for spontaneous fetal loss.
Conference Coverage
MedPAC eyes ‘incident to’ billing
Quality and access to care issues were raised by MedPAC officials and physician groups.
Conference Coverage
Novel IL-6 antibody slashes relapse rates in neuromyelitis optica
BERLIN – The monoclonal antibody satralizumab reduced by 62% relapses of neuromyelitis optica spectrum disorder over 24 weeks, as compared with...
Conference Coverage
Nf-L levels predictive of brain atrophy, disability in progressive MS
BERLIN – Future brain atrophy and 3-month confirmed disability worsening could be predicted from change in baseline levels of the potential MS...
Feature
Feds say ACA’s silver plan premiums will drop in 2019
But market corrections, not federal government action, may be driving the declines.
Conference Coverage
Low spinal cord volume linked to higher MS disability
BERLIN – Spinal cord volume tracked with disability level in patients with a mismatch between disability status and intracerebral lesion load.
Conference Coverage
Oligoclonal bands, initial seizures increase risk of post-ADEM epilepsy in children
BERLIN – Nearly all with post-ADEM epilepsy had antibodies against myelin oligodendrocyte glycoprotein (MOG).
FDA/CDC
Rivaroxaban gains indication for prevention of major cardiovascular events in CAD/PAD
Rivaroxaban (Xarelto) is the first direct oral anticoagulant to gain an indication for prevention of cardiovascular events.
Video
Bias in the clinical setting can impact patient care
Health care providers may harbor implicit, or unconscious, biases that contribute to health care disparities.
From the Journals
Treating cryptococcal meningitis in patients with HIV
One week of AmBd- and 5FC-based therapy, followed by fluconazole, appeared superior to other regimens for treating HIV-associated cryptococcal...